ACCEL Lite: Case Rates, Treatment, and Outcomes in AMI During the COVID-19 Pandemic

Nov 03, 2020   |  Alison Bailey, MD, FACC; Joseph Edward Marine, MD, MBA, FACC; Tyler J. Gluckman, MD, FACC; Yuvraj Chowdhury, MD

Podcast

Font Size
A
A
A

The coronavirus disease 2019 (COVID-19) pandemic has profoundly changed health care delivery worldwide. In this interview, Joseph Marine, Ty Gluckman, and Yuvraj Chowdhury discuss "Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic." This study adds to the growing body of literature that has noted worsened outcomes among those with non-communicable (non-infectious) diseases during the pandemic. It also reinforces that although social distancing with COVID-19 is recommended, medical distancing is not (#StopMedicalDistancing).

Like what you hear? ACCEL Subscribers enjoy 20+ insider interviews like these every month, with CME/MOC credit and other exclusive benefits. Subscribe today for more, and check out what's new at www.acc.org/ACCEL

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Clinical Topics: COVID-19 Hub

Keywords: ACCELLite, Coronavirus, severe acute respiratory syndrome coronavirus 2, COVID-19, Myocardial Infarction


< Back to Listings